Bradley Whitaker, DPM
Foot & Ankle Surgery · Tucson, AZNPI 1821089624
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (44.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Fusion Orthopedics USA, LLC accounts for 71.1% of it on its own, with 39 other manufacturers making up the rest. Reporting peaked in 2024 at $6,080 and has fallen 63.5% since, to $2,217 in 2025.
Across 128 payments — averaging $77.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fusion Orthopedics USA, LLC$7K
- Fusion Orthopedics, LLC.$549
- Koya Medical, Inc.$274
- Nevro Corp.$200
- Averitas Pharma Inc.$190
- Orthofix Medical, Inc.$179
- plus $1K from 34 others
What the payments were for
- Royalty or licence$4,37044%
- Consulting fees$2,20022%
- Travel & lodging$99910%
- Food & beverage$2,30523%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LapiLock$4,370
- Dayspring$821
- Koya Medical$274
How this compares
$9,874 in reported general payments places this provider in the 80th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 18 | $358 |
| Cephalexin | 36 | $334 |
| Ciclopirox | 16 | $320 |
| Oxycodone Hcl | 45 | $186 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 30 | $157 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Tucson
- Geoffrey LandisTucson$307K
- Bryan HallTucson$74K
- Jerome SteckTucson$64K
- Joseph BakerTucson$35K
- George AbdelmessiehTucson$25K
- Mohanad EltahirTucson$24K
- David HatchTucson$19K
- Gregory WalkerTucson$18K
- Jordan CraftonTucson$17K
- Richard QuintTucson$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.